Aetiology of type 2 diabetes in people with a 'normal’ body mass index: testing the personal fat threshold hypothesis
Open accessThe DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Weight loss in overweight or obese individuals with Type 2 diabetes (T2D) can normalize hepatic fat metabolism, decrease fatty acid oversupply to β cells and restore normoglycaemia. One in six people has BMI <27 kg/m2 at diagnosis, and their T2D is assumed to have different aetiology. The Personal Fat Threshold hypothesis postulated differing individual thresholds for lipid overspill and adverse effects on β-cell function. To test this hypothesis, people with Type 2 diabetes and body mass index <27kg/m2 (n = 20) underwent repeated 5% weight loss cycles. Metabolic assessments were carried out at stable weight after each cycle and after 12 months. To determine how closely metabolic features returned to normal, 20 matched normoglycemic controls were studied once. Between baseline and 12 months: BMI fell (mean ± SD), 24.8 ± 0.4 to 22.5 ± 0.4 kg/m2 (P<0.0001) (controls: 21.5 ± 0.5); total body fat, 32.1 ± 1.5 to 27.6 ± 1.8% (P<0.0001) (24.6 ± 1.5). Liver fat content and fat export fell to normal as did fasting plasma insulin. Post-meal insulin secretion increased but remained subnormal. Sustained diabetes remission (HbA1c < 48 mmol/mol off all glucose-lowering agents) was achieved by 70% (14/20) by initial weight loss of 6.5 (5.5–10.2)%. Correction of concealed excess intra-hepatic fat reduced hepatic fat export, with recovery of β-cell function, glycaemic improvement in all and return to a non-diabetic metabolic state in the majority of this group with BMI <27 kg/m2 as previously demonstrated for overweight or obese groups. The data confirm the Personal Fat Threshold hypothesis: aetiology of Type 2 diabetes does not depend on BMI. This pathophysiological insight has major implications for management.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The risk of type 2 diabetes rises with BMI over 23 kg/m² in people of European origin, 32 or at lower BMI with Asian ancestry, 33 with increased liver and pancreas fat, even at BMI levels below 25 kg/m²”
From 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study (2024) · cites this paper as [32]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global aetiology and epidemiology of type 2 diabetes mellitus and its complications
Zheng, Y., Ley, S. H., & Hu, F. B. (2018) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.151 · Cited by 5,697 · cited 1×
“Hence, the nature of T2D itself has been overlooked, and concepts of heterogeneity of aetiology in different weight groups have emerged [54].”
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Peters, C., Zhyzhneuskaya, S., Al-Mrabeh, A., Hollingsworth, K. G., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33102-1 · Cited by 2,095 · cited 1×
“The stepwise induction of weight loss in the T2D group identified that the BMI threshold for return to non-diabetic HbA 1c values was crossed at a median of 23.1 kg/m 2 with a median 6.5% weight loss, less than the 9.9% weight loss required for the higher-BMI group studied in DiRECT [23].”
InfluentialSelf-citationSzczepaniak, L. S., Nurenberg, P., Leonard, D., Browning, J. D., Reingold, J. S., Grundy, S., Hobbs, H. H., & Dobbins, R. L. (2005) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00064.2004 · Cited by 1,562 · cited 1×
“Although liver fat content at baseline in the present study was within the usually accepted normal range derived from the Dallas Heart Study with mean BMI 30kg/m 2 [24], it is important to consider what is normal for people with lower BMI values.”
McGarry, J. D. (2002) · Diabetes · doi:10.2337/diabetes.51.1.7 · Cited by 1,435 · cited 1×
“The fat overflow hypothesis and separately the concept that chronic excess fatty acid exposure could impair β -cell function are far from new [35–39].”
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Talchai, C., Xuan, S., Lin, H. V., Sussel, L., & Accili, D. (2012) · Cell · doi:10.1016/j.cell.2012.07.029 · Cited by 1,415
Lim, E. L., Hollingsworth, K. G., Aribisala, B. S., Chen, M. J., Mathers, J. C., & Taylor, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2204-7 · Cited by 1,164
Self-citationLipotoxicity in the Pathogenesis of Obesity-Dependent NIDDM: Genetic and Clinical Implications
Unger, R. H. (1995) · Diabetes · doi:10.2337/diab.44.8.863 · Cited by 1,100
Petersen, K. F., Dufour, S., Befroy, D., Lehrke, M., Hendler, R. E., & Shulman, G. I. (2005) · Diabetes · doi:10.2337/diabetes.54.3.603 · Cited by 911 · cited 1×
“The return to normal levels of liver fat after dietary weight loss in T2D, first demonstrated by Petersen and colleagues [17], emphasises the tight relationship between liver fat content, hepatic insulin sensitivity and restraint of hepatic glucose output by insulin [18–20].”
The complex link between NAFLD and type 2 diabetes mellitus - mechanisms and treatments
Targher, G., Corey, K. E., Byrne, C. D., & Roden, M. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00448-y · Cited by 850
Lee, Y., Hirose, H., Ohneda, M., Johnson, J. H., McGarry, J. D., & Unger, R. H. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.23.10878 · Cited by 836 · cited 1×
“Onset of T2D is likely to relate primarily to the β -cell functional insulin secretory capacity [31], confirmed in studies of remission and recurrence with weight regain in people with wide range of T2D duration [5,21,32].”
Research works printed but not linked: 2
- Federation ID (2021) IDF Diabetes Atlas. Available from: https://diabetesatlas.org/atlas/tenth-edition. Accessed 24 Aug 2023.
- White M.G., Marshall H.L., Rigby R., Huang G.C., Amer A., Booth T. et al. (2013) Expression of mesenchymal and α-cell phenotypic markers in islet β-cells in recently diagnosed diabetes. Diabetes Care. 36, 3818– 3820 10.2337/dc13-0705 24062329 PMC3816907 · DOI · Paper page
Cited by
Lean, M. E., Leslie, W. S., Barnes, A. C., Brosnahan, N., Thom, G., McCombie, L., Kelly, T., Irvine, K., Peters, C., Zhyzhneuskaya, S., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00385-6 · Cited by 186
Self-citationNielsen, R. L., Monfeuga, T., Kitchen, R. R., Egerod, L., Leal, L. G., Schreyer, A. T. H., Gade, F. S., Sun, C., Helenius, M., Simonsen, L., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46663-4 · Cited by 91
“This is possibly due to the presence of a personal fat threshold, as it has been seen that weight loss can lead to type 2 diabetes remission even in those who do not have obesity 20 .”
The Causal Role of Ectopic Fat Deposition in the Pathogenesis of Metabolic Syndrome
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252413238 · Cited by 83
Valabhji, J., Gorton, T., Barron, E., Safazadeh, S., Earnshaw, F., Helm, C., Virr, M., Kernan, J., Crowe, S., Aveyard, P., et al. (2024) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(24)00194-3 · Cited by 72
Self-citationJanssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105488 · Cited by 253
“In addition, it has been suggested (but at the moment not documented by studies) that different ethnicities have different PFTs, and this may help to explain why the prevalence of diabetes substantially differs among ethnic groups [115,116].”
BackgroundMethodPrediabetes remission to reduce the global burden of type 2 diabetes
Sandforth, L., Kullmann, S., Sandforth, A., Fritsche, A., von Schwartzenberg, R. J., Stefan, N., & Birkenfeld, A. L. (2025) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2025.01.004 · Cited by 58
Managing early-onset type 2 diabetes in the individual and at the population level
Misra, S., Khunti, K., Goyal, A., Gable, D., Armocida, B., Tandon, N., Sachdev, P., Wild, S. H., Hivert, M.-F., & Beran, D. (2025) · The Lancet · doi:10.1016/s0140-6736(25)01067-0 · Cited by 47
An overview of diabetes mellitus in pregnant women with obesity
Bashir, M., Fagier, Y., Ahmed, B., & Konje, J. C. (2024) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2024.102469 · Cited by 45
von Schwartzenberg, R. J., Arreola, E. V., Sandforth, A., Hanson, R. L., & Birkenfeld, A. L. (2024) · Diabetologia · doi:10.1007/s00125-024-06178-5 · Cited by 33
“In T2D, elegant studies in the DIRECT trial showed that the difference between people with diabetes going into remission and those not going into remission was the ability of beta-cells to respond to weight loss with an improvement in function and insulin secretion [7,8].”
BackgroundRyan, L., Quigley, F., Birney, S., Crotty, M., Conlan, O., & Walsh, J. C. (2024) · Health Expectations · doi:10.1111/hex.14098 · Cited by 31
“Yet, as individuals differ in body composition, fat distribution, and how the body uses fat, the amount of excess adiposity that is symptomatic of impaired health varies considerably [6 – 8].”
BackgroundWu, H., Yang, A., Lau, E. S. H., Zhang, X., Fan, B., Ma, R. C. W., Kong, A. P. S., Chow, E., So, W.-Y., Chan, J. C. N., et al. (2024) · PLOS Medicine · doi:10.1371/journal.pmed.1004327 · Cited by 24
Re-evaluating the concept of remission in type 2 diabetes: a call for patient-centric approaches
Khunti, K., Papamargaritis, D., Aroda, V. R., Anjana, R. M., & Kashyap, S. R. (2025) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(25)00134-2 · Cited by 22
Janssen, J. A. M. J. L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26189191 · Cited by 20
“From that moment on, excess liver fat accumulation, excess hepatic fat export, and exposure of beta cells to excess lipids will be promoted [69,86].”
Geladari, E. V., Kounatidis, D. C., Christodoulatos, G. S., Psallida, S., Pavlou, A., Geladari, C. V., Sevastianos, V., Dalamaga, Μ., & Vallianou, N. G. (2025) · Nutrients · doi:10.3390/nu17132098 · Cited by 19
“This model explains the occurrence of MASLD in individuals with a normal BMI [26].”
Moreno, Ó., Reyes‐García, R., Pardo, I. M., López-Martínez, M., & Soler, M. J. (2024) · Clinical Kidney Journal · doi:10.1093/ckj/sfae039 · Cited by 15
“Body fat quality and location matter— even people with a body mass index ( BMI) of 27 kg/m 2 could achieve remission of T2D with dietary WL, accompanied by the same underlying pathogenic mechanisms as in heavier people [18 ].”
BackgroundUltra-processed foods and type 2 diabetes: more fundamental research is needed
Janssen, J. A. M. J. L. (2024) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2024.101084 · Cited by 15
Chimoriya, R., Mitlehner, K., Khoo, C. L., Osuagwu, U. L., Thomson, R. J., Si, L., Lean, M. E. J., Simmons, D. S., & Piya, M. K. (2024) · Journal of Diabetes Research · doi:10.1155/2024/2350551 · Cited by 15
“Moreover, a recent study demonstrated that people with BMI 27 kg/m 2 , which represents 1 in 6 people of white European ethnicity presenting with T2DM, can also achieve remission by a more modest weight loss [39].”
BackgroundUltra-Processed Foods and Type 2 Diabetes Mellitus: What Is the Evidence So Far?
Vallianou, N. G., Evangelopoulos, A. A., Tzivaki, I., Daskalopoulou, S., Adamou, A., Zafeiri, G. C. M., Karampela, Ι., Dalamaga, Μ., & Kounatidis, D. C. (2025) · Biomolecules · doi:10.3390/biom15020307 · Cited by 17
“If the PFT is exceeded, accumulation of ectopic fat occurs, mainly in the liver, leading to excess exposure of pancreatic beta cells to fat, over-functioning of beta cells, and ultimately their exhaustion and predisposition to the development of T2DM [24,25].”
Preservation of β-Cells as a Therapeutic Strategy for Diabetes
Taneera, J., & Saber-Ayad, M. (2023) · Hormone and Metabolic Research · doi:10.1055/a-2239-2668 · Cited by 11
“Crucially, the study underscores the pivotal role of shedding detrimental fat from the liver and pancreas in achieving this remission [92].”
BackgroundBull, C. J., Hazelwood, E., Legge, D., Corbin, L. J., Richardson, T. G., Lee, M. A., Yarmolinsky, J. W., Smith-Byrne, K., Hughes, D. A., Johansson, M., et al. (2024) · EBioMedicine · doi:10.1016/j.ebiom.2024.104977 · Cited by 13
Self-citationAstbury, N. M. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15855 · Cited by 12
“39 The DiRECT trial and the trials that followed have been a water-shed moment for type 2 diabetes treatment, showing that remission is a realistic goal for many people.”
BALDASSARRE, M. P. A., Dalmazi, G. D., Coluzzi, S., Carrieri, F., Febo, F., Centorame, G., Cassino, P., Piacentino, L., Baroni, M. G., Consoli, A., et al. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13113054 · Cited by 13
“It is crucial to consider that achieving a significant weight loss, irrespective of the initial starting body weight [31] is of fundamental importance in reducing cardiovascular risk [32].”
BackgroundPractical strategies to manage obesity in type 2 diabetes
Rodbard, H. W., Barnard-Kelly, K. D., Pfeiffer, A. F. H., Mauersberger, C., Schnell, O., & Giorgino, F. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15556 · Cited by 10
“121 TABLE 1 Examples of how to integrate supportive and motivational communication when talking to a person with obesity. is always a person's perception of reality, that is, their beliefs and emotions, that shapes motivation and behaviour (Figure 2).”
BackgroundRemission of type 2 diabetes: position statement of the Italian society of diabetes (SID)
Capoccia, D., Leonetti, F., Natali, A., Tricò, D., Perrini, S., Sbraccia, P., Guglielmi, V., & On behalf of the Italian Society of Diabetes (SID) (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02317-x · Cited by 11
“This unexpected finding could be justified by the poor ability of BMI alone to recognize some obesity phenotypes associated with altered distribution of body fat and presence of metabolically unfavorable ectopic fat, in the absence of significant weight gain [69–71].”
BackgroundAetiology of type 2 diabetes: an experimental medicine odyssey
Taylor, R. (2025) · Diabetologia · doi:10.1007/s00125-025-06428-0 · Cited by 10
“The ReTUNE study (Reversal of Type 2 diabetes Upon Normalisation of Energy intake in the non-obese) specifically tested whether an individual threshold could be detected at which accumulation of fat in liver and pancreas caused diabetes [67].”
InfluentialSelf-citationMay, W., Goedecke, J. H., & Conradie-Smit, M. (2025) · South African Medical Journal · doi:10.7196/samj.2025.v115i9b.3600 · Cited by 8
“…- 27 kg/m 2 ) and showed a 70% remission rate at 1 year with a median weight loss of 6.5% (5.5 - 10.2%), further validating the concept of the PFT. [62] These studies provide compelling evidence for the existence of organ-specific fat thresholds, which are specific to each individual and vary…”
InfluentialDissanayake, H. A., Fernando, D., Nilaweera, A. I., Munasinghe, T. D., Kaushalya, C. M. A. U., Pulukkody, M. M., & Katulanda, P. (2024) · Diabetic Medicine · doi:10.1111/dme.15422 · Cited by 7
“It is also possible that the South Asians had a lower ‘personal fat threshold’ and had higher liver and pancreatic fat mass at a given body weight compared with Caucasians 16,17 which could therefore be reduced with a relatively lesser calorie restriction.”
Karmacharya, B. M., Sapkota, S., Rai, P., Nikolaou, C. K., Kasti, R., Bhattarai, J., Maharjan, R., Shrestha, A., Shrestha, A., Bhattarai, B., et al. (2024) · The Lancet Regional Health - Southeast Asia · doi:10.1016/j.lansea.2024.100465 · Cited by 9
“8 14 While this evidence is rapidly changing the priorities for diabetes care in Western countries, for most people in low-income and middle-income countries (LMICs) and across South Asia, including Nepal, the formula diet interventions used in the RCTs are unaffordable.”
BackgroundThe Twin Cycle Hypothesis of type 2 diabetes aetiology: From concept to national NHS programme
Taylor, R. (2025) · Experimental Physiology · doi:10.1113/ep092009 · Cited by 7
“In a cohort of people with BMI 21–27 kg/m 2 , 70% achieved remission of diabetes at a median weight loss of 6.5 kg with the anticipated wide range of 5.5–10.2% weight loss (Taylor et al., 2023).”
InfluentialSelf-citationOrtega, E., Redondo‐Antón, J., Díaz‐Cerezo, S., Santos, M. R., & Romera, I. (2025) · Advances in Therapy · doi:10.1007/s12325-025-03230-7 · Cited by 6
Schuppelius, B., Lalama, E., Zhang, J., Rüther, K. J. A., Csanalosi, M., Kabisch, S., Christ, A., Latz, E., Kraenkel, N., Pivovarova‐Ramich, O., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113159 · Cited by 6
Schwartz, S. S., & Herman, M. E. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1394805 · Cited by 6
Obesity as a disease: a pressing need for alignment
Grannell, A., & le Roux, C. W. (2024) · International Journal of Obesity · doi:10.1038/s41366-024-01582-8 · Cited by 12
“A uni fi ed theory of what obesity is may require the integration additional models and concepts such as the dual intervention point model, the personal fat threshold concept and the Leeds model of appetite regulation [5, 11, 12].”
BackgroundInsights into optimal BMI from the GlasVEGAS study
Chun Kwan, O., & Chan, J. C. N. (2024) · Nature Metabolism · doi:10.1038/s42255-024-01088-7 · Cited by 6
Malandrino, N., Metter, E. J., Simonsick, E. M., Egan, J. M., Chia, C. W., Walston, J. D., Ferrucci, L., & Kalyani, R. R. (2024) · Journal of the Endocrine Society · doi:10.1210/jendso/bvae156 · Cited by 8
Why Early, Large-scale Weight Loss Is the Future of Type 2 Diabetes Care
Sattar, N. A., & Buse, J. B. (2025) · Diabetes Care · doi:10.2337/dci25-0069 · Cited by 5
Mildly elevated liver lipid content is characterised by reduced insulin sensitivity
Tuomola, N., Rebelos, E., Latva‐Rasku, A., Bucci, M., Immonen, H., Saunavaara, V., Laine, S., Sjöros, T., Garthwaite, T., Raiko, J. R. H., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101535 · Cited by 5
Type 2 diabetes mellitus: Isn’t it time to update the terminology?
Raveendran, A. V. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i9.107517 · Cited by 4
Cinti, F., Mezza, T., Severi, I., Moffa, S., Giuseppe, G. D., Capece, U., Ciccarelli, G., Soldovieri, L., Brunetti, M., Morciano, C., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112029 · Cited by 4
Fan, Y., Chow, E., Lim, C. K. P., Hou, Y. J., Tsoi, S. T. F., Fan, B., Lau, E. S. H., Kong, A. P. S., Ronald, C. W., Wu, H., et al. (2024) · Diabetes · doi:10.2337/db23-0966 · Cited by 4
Chiriacò, M., Tricò, D., Petrie, J. R., Gabriel, R., Gastaldelli, A., Nolan, J. J., Lalic, N. M., Mingrone, G., Mari, A., & Natali, A. (2025) · Diabetologia · doi:10.1007/s00125-025-06643-9 · Cited by 5
“Indeed, weight loss has recently been shown to induce diabetes remission even in individuals with a BMI below 27 kg/m 2 [35].”
Pál, S., & Sepsey, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15041385 · Cited by 3
“The high OR in the 40–59 age group supports lowering the universal screening age to 35 (as recently updated by the ADA), regardless of weight, to also capture these cases, still receiving less attention [33].”
The Global Obesity Epidemic: Epidemiology, Health Burden and Policy Priorities
Henney, A. E., & Wilding, J. P. H. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.84 · Cited by 4
Tripathi, P., Kadam, N., Kathrikolly, T., Tiwari, D., Vyawahare, A., Sharma, B., Ganla, M., & Saboo, B. (2025) · PLOS One · doi:10.1371/journal.pone.0333114 · Cited by 2
Deviation From Genetically Predicted BMI and All‐Cause Mortality: A Cohort Study in the UK Biobank
Zilhäo, N. R., Zhang, J., Boomsma, D. I., Sørensen, T. I. A., & Dahm, C. C. (2025) · Obesity · doi:10.1002/oby.70042 · Cited by 3
Brown, E. E., Bilson, J., Alam, U., Goff, L. M., Kemp, G. J., Pfeiffer, A. F. H., Weickert, M. O., Umpleby, A. M., Byrne, C. D., & Cuthbertson, D. J. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112997 · Cited by 2
Sapkota, S., Rai, P., Karmacharya, B. M., Bhattarai, J., Shrestha, A., Maharjan, R., Kasti, R., Leeds, A., Lean, M. E. J., & Nikolaou, C. K. (2025) · Diabetic Medicine · doi:10.1111/dme.70184 · Cited by 2
Yang, M. A., Pu, F., Guo, Y., Yang, Y., Tang, R., Luo, Y., Li, Q., & Fan, Y. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113221 · Cited by 2
Bosy‐Westphal, A., Enderle, J., Norman, K., & Müller, M. J. (2026) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.70334 · Cited by 2
“Evidence suggests that each individual possesses a personal fat threshold, beyond which the accumulation of intrahepatic and intrapancreatic fat impairs insulin secretion, exacerbates insulin resistance and thereby increases the risk of type 2 diabetes (T2D) [9–11].”
Tian, X., Tang, Y., Hu, R., Ye, J., Chen, H., & Wu, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1341531 · Cited by 4
Holman, R. R. (2025) · Diabetes · doi:10.2337/db24-0719 · Cited by 1
Self-citationJia, X., Du, K., Zhu, Y., Xie, L., Zhang, T., Yang, L., Hu, Y., Lan, C., & Zhang, Q. (2025) · Human Mutation · doi:10.1155/humu/5536318 · Cited by 1
“Two insulin and glycemic-related traits were considered [17].”
Wei, Y., Ran, Y., Wang, J., Pei, F., Cui, L., Chen, S., Wu, S., & Zhou, L. (2024) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000002794 · Cited by 1
“Additionally, the Personal Fat Threshold hypothesis postulates that the subcutaneous fat storage capacity of individuals may greatly differ, and when individuals cannot store triglycerides safely, excessive liver fat accumulation and diabetes will occur [22].”
Diabetes Update 2024 – wertvolle neue Erkenntnisse
Scherbaum, W. A. (2024) · Die Diabetologie · doi:10.1007/s11428-024-01205-w
Taylor, R. (2024) · British Journal of Diabetes · doi:10.15277/bjd.2024.450
Self-citationElmagarmid, K. A., Fadlalla, M. A., Jose, J., Arredouani, A., & Bensmail, H. (2024) · Scientific Reports · doi:10.1038/s41598-024-73476-8
Abweichung vom genetisch prognostizierten Body-Mass-Index als Risikomarker?
Müssig, K. (2025) · Info Diabetologie · doi:10.1007/s15034-024-5061-4
Comprehensive healthspan assessments and influence of sex as a biological variable in aging rats
Chandra, A., Aversa, Z., Zhang, X., Farr, J. N., David, A., Sharma, R., Tchkonia, T., Kirkland, J. L., Robbins, P. D., Niedernhofer, L. J., et al. (2026) · Aging · doi:10.1101/2025.09.22.677661
Enfermedad del hígado graso no alcohólico en pacientes con diagnóstico de diabetes mellitus tipo 2
Mejía, J., Reyna-Villasmil, N., Fernández-Ramírez, A., & Reyna‐Villasmil, E. (2024) · Revista Venezolana de Endocrinología y Metabolismo · doi:10.53766/rvem/2024.22.1.02
Clinical ultrasound for the characterisation of obesity: beyond the body mass index
Rivas, J. A. P., Millán, I. F. A., Romero, L. M. B., & Guerra, L. C. (2025) · Revista Clínica Española (English Edition) · doi:10.1016/j.rceng.2025.502392
Ecografía clínica para la caracterización de la obesidad: más allá del índice de masa corporal
Rivas, J. A. P., Millán, I. F. A., Romero, L. M. B., & Guerra, L. C. (2025) · Revista Clínica Española · doi:10.1016/j.rce.2025.502392
Vincenzo, A. D., & Rossato, M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-13825-6.00348-4
Rahman, T. (2025) · Mspace (University of Manitoba)
Fuel toxicity-associated spectrum (FTAS): a unifying nomenclature for metabolic disorders
Sureshkumar, P. (2026) · Cardiovascular Diabetology – Endocrinology Reports · doi:10.1186/s40842-026-00282-8
“This variability is explained by the conceptual ‘personal fat threshold’, the individual-specific capacity for subcutaneous fat storage before ectopic deposition occurs [20, 23].”
Kasahara, K., Okada, H., Ide, H., Nakajima, H., Ushigome, E., Nakanishi, N., Hamaguchi, M., Kurogi, K., Murata, H., Tsuda, E., et al. (2026) · Obesity · doi:10.1002/oby.70186
“Under Japan's SHC system, our study focused on lifestyle intervention with a feasible 2cm2kg target; even small WC or BW reductions may have meaningful metabolic effects given Japanese individuals' elevated metabolic risk [22].”
InfluentialTwenefour, D. (2026) · Wiley eBooks · doi:10.1002/9781394206148.mdp0073
The role of noradrenergic innervation and β-cell dedifferentiation in diabetes
AVOLIO, A., Morciano, C., Gugliandolo, S., Splendore, A., Capece, U., Mezza, T., Giuseppe, G. D., Ciccarelli, G., Soldovieri, L., Brunetti, M., et al. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.04.005
Adipose Tissue Dysfunction in Metabolic Dysfunction-Associated Steatotic Liver Disease
Cruz, A. J. L., & Yuan, L. (2026) · Cells · doi:10.3390/cells15151377 · Cited by 1
“In the ReTUNE study [23], 20 patients with type 2 diabetes and BMI 27 kg/m 2 underwent repeated 5% weight-loss cycles with metabolic phenotyping at each stable-weight plateau through 12 months.”
InfluentialTam, K., & Lund, H. (2026) · Springer eBooks · doi:10.1007/978-3-031-90919-1_22-1
Fontes‐Villalba, M. (2025) · Lund University Publications (Lund University)
Chen, S.-C., Huang, Y., Li, P.-Y., Chen, J.-C., Meyerowitz‐Katz, G., Yang, S., & Su, P. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71266
“These findings suggest that some observed benefits associated with GLP-1 RA use may extend to adults with lower-BMI T2D [16, 18, 27, 28].”
Génétique et épigénétique : leur rôle dans le développement du diabète de type 2
Grandjean, V. (2026) · EMC - Endocrinologie - Nutrition · doi:10.1016/s1155-1941(25)79304-x
Ispas, S., Gupta, A., Diaz-Gutierrez, M., Velásquez‐Rimachi, V., Calderon, Z. A. M., Rabbani, S. A., Madera, D., Santos, A. C. F. D. F., Kumar, S., Li, Y., et al. (2026) · Biomolecules · doi:10.3390/biom16111543
Jiménez-Flores, E., Reytor-González, C., Gavilanes, D. J., Rossetti, G., Pilone, V., Parrillo, L., Cavallo, M., Cobellis, L., Simancas-Racines, D., & Schiavo, L. (2026) · Nutrients · doi:10.3390/nu18183075
“Taylor et al. [83] directly tested the personal fat threshold hypothesis in 20 individuals with T2D who had a mean BMI of only 24.8 kg/m 2 .”
InfluentialBMI-anchored transcriptomics uncovers oxidative and inflammatory poles of obesity heterogeneity
Su, Y.-Y., Linnaeus, B., Chen, Y.-C., Gjermeni, E., Benedikt, G., Sandy, R., Jasaszwili, M., Eliseo, P.-V. S., Hoffmann, A., Ghosh, A., et al. (2026) · Molecular Metabolism · doi:10.1016/j.molmet.2026.102462
An, X., Feng, Y., & Li, J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.2008215
Metadata
- Authors
- Taylor, R., Barnes, A. C., Hollingsworth, K. G., Irvine, K. M., Solovyova, A. S., Clark, L., Kelly, T., Martin-Ruiz, C., Romeres, D., Koulman, A., Meek, C. M., Jenkins, B., Cobelli, C., & Holman, R. R.
- Affiliations
- Newcastle University (GB)
- University of Virginia (US)
- University of Cambridge (GB)
- 5Wellcome Trust-MRC Institute of Metabolic Science, University of Cambridge, Box 289, Cambridge Biomedical Campus, Cambridge, U.K.
- University of Padua (IT)
- University of Oxford (GB)
- Corresponding author
- Taylor, Roy
- ORCID
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2023-08
- Volume
- 137
- Issue
- 16
- Pages
- 1333-1346
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- PMC
- PMC10472166
- OpenAlex
- W4385969638
- Cited by
- 71
- References
- 56
- Citations by year
- 2026: 16 · 2025: 24 · 2024: 31
- FWCI
- 14.57
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Clinical Science (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Apollo (University of Cambridge) (submittedVersion, cc-by)
- Newcastle University ePrints (Newcastle Univesity) (cc-by)
- Funders
- Diabetes UK (17/0005645)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, normal body mass index, weight loss, diabetes remission, liver fat, beta-cell function, insulin secretion, total body fat
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Obesity, Weight Loss, Body Mass Index, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.